{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T22:43:19Z","timestamp":1710283399478},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,14]]},"DOI":"10.7759\/cureus.45238","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T15:56:22Z","timestamp":1694706982000},"source":"Crossref","is-referenced-by-count":1,"title":["Developmental Approaches to Chronic Pain: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Nikita  P","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad  M","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakash","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002291","article-title":"Prevalence of chronic pain among adults in the United States","volume":"163","author":"Yong RJ","year":"2022","unstructured":"Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022, 163:e328-32. 10.1097\/j.pain.0000000000002291","journal-title":"Pain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq323","article-title":"When does acute pain become chronic?","volume":"105 Suppl 1","author":"Voscopoulos C","year":"2010","unstructured":"Voscopoulos C, Lema M. When does acute pain become chronic?. Br J Anaesth. 2010, 105 Suppl 1:i69-85. 10.1093\/bja\/aeq323","journal-title":"Br J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/eurasianjmed.2018.0010","article-title":"Effects of nonsteroidal anti-inflammatory drugs at the molecular level","volume":"50","author":"Gunaydin C","year":"2018","unstructured":"Gunaydin C, Bilge SS. Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med. 2018, 50:116-21. 10.5152\/eurasianjmed.2018.0010","journal-title":"Eurasian J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective","volume":"180","author":"Bindu S","year":"2020","unstructured":"Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020, 180:114147. 10.1016\/j.bcp.2020.114147","journal-title":"Biochem Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.22164025.x","article-title":"Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies","volume":"10 Suppl 2","author":"Brattsand R","year":"1996","unstructured":"Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther. 1996, 10 Suppl 2:81-90; discussion 91-2. 10.1046\/j.1365-2036.1996.22164025.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman AL","year":"2001","unstructured":"Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001, 33:289-94. 10.1097\/00004836-200110000-00006","journal-title":"J Clin Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan H","year":"2012","unstructured":"Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012, 6:11-6. 10.1177\/2049463712438493","journal-title":"Br J Pain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.301966","article-title":"Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review","volume":"104","author":"King NB","year":"2014","unstructured":"King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health. 2014, 104:e32-42. 10.2105\/AJPH.2014.301966","journal-title":"Am J Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112483","article-title":"Analgesic mechanisms of antidepressants for neuropathic pain","volume":"18","author":"Obata H","year":"2017","unstructured":"Obata H. Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci. 2017, 18:10.3390\/ijms18112483","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00052","article-title":"The delta-opioid receptor; a target for the treatment of pain","volume":"13","author":"Quirion B","year":"2020","unstructured":"Quirion B, Bergeron F, Blais V, Gendron L. The delta-opioid receptor; a target for the treatment of pain. Front Mol Neurosci. 2020, 13:52. 10.3389\/fnmol.2020.00052","journal-title":"Front Mol Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.09.007","article-title":"Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay","volume":"25","author":"Storaska AJ","year":"2013","unstructured":"Storaska AJ, Mei JP, Wu M, et al.. Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay. Cell Signal. 2013, 25:2848-55. 10.1016\/j.cellsig.2013.09.007","journal-title":"Cell Signal"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2008.00687.x","article-title":"Novel peptide ligands of RGS4 from a focused one-bead, one-compound library","volume":"72","author":"Roof RA","year":"2008","unstructured":"Roof RA, Sobczyk-Kojiro K, Turbiak AJ, et al.. Novel peptide ligands of RGS4 from a focused one-bead, one-compound library. Chem Biol Drug Des. 2008, 72:111-9. 10.1111\/j.1747-0285.2008.00687.x","journal-title":"Chem Biol Drug Des"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00005","article-title":"Regulator of G-protein signaling (RGS) protein modulation of opioid receptor signaling as a potential target for pain management","volume":"13","author":"Senese NB","year":"2020","unstructured":"Senese NB, Kandasamy R, Kochan KE, Traynor JR. Regulator of G-protein signaling (RGS) protein modulation of opioid receptor signaling as a potential target for pain management. Front Mol Neurosci. 2020, 13:5. 10.3389\/fnmol.2020.00005","journal-title":"Front Mol Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(04)89017-7","article-title":"Yeast-based screening for inhibitors of RGS proteins","volume":"389","author":"Young KH","year":"2004","unstructured":"Young KH, Wang Y, Bender C, et al.. Yeast-based screening for inhibitors of RGS proteins. J Methods Enzymol. 2004, 389:277-301. 10.1016\/S0076-6879(04)89017-7","journal-title":"J Methods Enzymol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.02.013","article-title":"Spinal cytochrome P450c17 plays a key role in the development of neuropathic mechanical allodynia: Involvement of astrocyte sigma-1 receptors","volume":"149","author":"Choi SR","year":"2019","unstructured":"Choi SR, Roh DH, Yoon SY, et al.. Spinal cytochrome P450c17 plays a key role in the development of neuropathic mechanical allodynia: Involvement of astrocyte sigma-1 receptors. Neuropharmacology. 2019, 149:169-80. 10.1016\/j.neuropharm.2019.02.013","journal-title":"Neuropharmacology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00153","article-title":"Spinal interleukin-1\u03b2 inhibits astrocyte cytochrome p450c17 expression which controls the development of mechanical allodynia in a mouse model of neuropathic pain","volume":"12","author":"Choi SR","year":"2019","unstructured":"Choi SR, Han HJ, Beitz AJ, Lee JH. Spinal interleukin-1\u03b2 inhibits astrocyte cytochrome p450c17 expression which controls the development of mechanical allodynia in a mouse model of neuropathic pain. Front Mol Neurosci. 2019, 12:153. 10.3389\/fnmol.2019.00153","journal-title":"Front Mol Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047569","article-title":"Endogenous opioids in wound-site neutrophils of sternotomy patients","volume":"7","author":"Awad H","year":"2012","unstructured":"Awad H, Abas M, Elgharably H, et al.. Endogenous opioids in wound-site neutrophils of sternotomy patients. PLoS One. 2012, 7:e47569. 10.1371\/journal.pone.0047569","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00217","article-title":"Granulocyte-colony stimulating factor-induced neutrophil recruitment provides opioid-mediated endogenous anti-nociception in female mice with oral squamous cell carcinoma","volume":"12","author":"Scheff NN","year":"2019","unstructured":"Scheff NN, Alemu RG, Klares R 3rd, Wall IM, Yang SC, Dolan JC, Schmidt BL. Granulocyte-colony stimulating factor-induced neutrophil recruitment provides opioid-mediated endogenous anti-nociception in female mice with oral squamous cell carcinoma. Front Mol Neurosci. 2019, 12:217. 10.3389\/fnmol.2019.00217","journal-title":"Front Mol Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1182-9","article-title":"Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9\/2","volume":"15","author":"Pan C","year":"2018","unstructured":"Pan C, Wang C, Zhang L, et al.. Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9\/2. J Neuroinflammation. 2018, 15:187. 10.1186\/s12974-018-1182-9","journal-title":"J Neuroinflammation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00220","article-title":"TIMP-1 attenuates the development of inflammatory pain through MMP-dependent and receptor-mediated cell signaling mechanisms","volume":"12","author":"Knight BE","year":"2019","unstructured":"Knight BE, Kozlowski N, Havelin J, King T, Crocker SJ, Young EE, Baumbauer KM. TIMP-1 attenuates the development of inflammatory pain through MMP-dependent and receptor-mediated cell signaling mechanisms. Front Mol Neurosci. 2019, 12:220. 10.3389\/fnmol.2019.00220","journal-title":"Front Mol Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404915101","article-title":"Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain","volume":"101","author":"Nassar MA","year":"2004","unstructured":"Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, Dickenson AH, Wood JN. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A. 2004, 101:12706-11. 10.1073\/pnas.0404915101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2695-04.2004","article-title":"Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy","volume":"24","author":"Cummins TR","year":"2004","unstructured":"Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci. 2004, 24:8232-6. 10.1523\/JNEUROSCI.2695-04.2004","journal-title":"J Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2006.03.014","article-title":"T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression","volume":"200","author":"Kleinschnitz C","year":"2006","unstructured":"Kleinschnitz C, Hofstetter HH, Meuth SG, Braeuninger S, Sommer C, Stoll G. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol. 2006, 200:480-5. 10.1016\/j.expneurol.2006.03.014","journal-title":"Exp Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00216","article-title":"T cells as an emerging target for chronic pain therapy","volume":"12","author":"Laumet G","year":"2019","unstructured":"Laumet G, Ma J, Robison AJ, Kumari S, Heijnen CJ, Kavelaars A.  T cells as an emerging target for chronic pain therapy. Front Mol Neurosci. 2019, 12:216. 10.3389\/fnmol.2019.00216","journal-title":"Front Mol Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3852","article-title":"The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase","volume":"21","author":"Vicu\u00f1a L","year":"2015","unstructured":"Vicu\u00f1a L, Strochlic DE, Latremoliere A, et al.. The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase. Nat Med. 2015, 21:518-23. 10.1038\/nm.3852","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.636506","article-title":"Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system","volume":"290","author":"Kobayashi Y","year":"2015","unstructured":"Kobayashi Y, Kiguchi N, Fukazawa Y, Saika F, Maeda T, Kishioka S. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J Biol Chem. 2015, 290:12603-13. 10.1074\/jbc.M115.636506","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.01.005","article-title":"Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells","volume":"234","author":"Leger T","year":"2011","unstructured":"Leger T, Grist J, D'Acquisto F, Clark AK, Malcangio M. Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells. J Neuroimmunol. 2011, 234:19-26. 10.1016\/j.jneuroim.2011.01.005","journal-title":"J Neuroimmunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190456","article-title":"Targeting the interleukin-17 immune axis for cancer immunotherapy","volume":"217","author":"Vitiello GA","year":"2020","unstructured":"Vitiello GA, Miller G. Targeting the interleukin-17 immune axis for cancer immunotherapy. J Exp Med. 2020, 217:10.1084\/jem.20190456","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23062924","article-title":"Peptide human neutrophil elastase inhibitors from natural sources: an overview","volume":"23","author":"Marinaccio L","year":"2022","unstructured":"Marinaccio L, Stefanucci A, Scioli G, Della Valle A, Zengin G, Cichelli A, Mollica A. Peptide human neutrophil elastase inhibitors from natural sources: an overview. Int J Mol Sci. 2022, 23:10.3390\/ijms23062924","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0885-3924(00)00218-9","article-title":"Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review","volume":"20(6)","author":"Sally C","year":"2000","unstructured":"Sally C, Andrew RM, Henry JM, et al.. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manag. 2000, 20(6):449-458. 10.1016\/s0885-3924(00)00218-9","journal-title":"J Pain Symptom Manag"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159032-developmental-approaches-to-chronic-pain-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:55Z","timestamp":1707509095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159032-developmental-approaches-to-chronic-pain-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.45238","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}